Andere Sprachen Ajanta Pharma Limited

Aktien

A14QQH

INE031B01049

AJANTPHARM

Verzögert NSE India S.E. Andere Börsenplätze 13:42:29 30.04.2024			% 5 Tage	% 1. Jan.
2.215 ^INR	+0,13 %		+5,93 %	+6,33 %

26.04.	Der Vorstand von Ajanta Pharma Limited beabsichtigt, am 2. Mai 2024 einen Aktienrückkauf zu starten.	CI
02.02.	Ajanta Pharma verzeichnet Zuwachs beim konsolidierten Nettogewinn im 3.	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Ajanta Pharma Limited?s Board intends to launch an Equity Buyback on May 2, 2024.	26.04.
Ajanta Pharma Posts Gains in Fiscal Q3 Consolidated Net Profit	02.02.
Ajanta Pharma Limited Approves Second Interim Dividend for the Year Fiscal Year 2024, Payable on or After 19th February 2024	31.01.
Ajanta Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	31.01.
Ajanta Pharma Board to Consider Second Interim Dividend for Fiscal 2024	25.01.
Ajanta Pharma Limited Provides Earnings Guidance for the Full Year of Fiscal 2024	31.10.23
Ajanta Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	31.10.23
Ajanta Pharma Gets US FDA Nod for Topiramate Extended-Release Capsules	31.08.23
Ajanta Pharma Limited Receives Final Approval from US FDA for Topiram Extended Release Capsules	30.08.23
Ajanta Pharma Logs Increase in Fiscal Q1 Consolidated Profit	28.07.23
Ajanta Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	27.07.23
Ajanta Pharma Board to Consider Interim Dividend for Fiscal 2024	24.07.23
Ajanta Pharma Limited Confirms the Interim Dividend for the Year Ended 31 March 2023	18.07.23
Ajanta Pharma Gets No Observations After US FDA's Inspection of API Facility in Hyderabad, India	26.06.23
Ajanta Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	05.05.23
Ajanta Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2023	05.05.23
Tranche Update on Ajanta Pharma Limited's Equity Buyback Plan announced on March 10, 2023.	20.04.23
Ajanta Pharma Limited's Equity Buyback announced on March 10, 2023, has closed with 2,210,500 shares, representing 1.73% for ¥3,149.96 million.	10.04.23
Ajanta Pharma Board OKs Up To INR3.2 Billion Share Buyback	10.03.23
Ajanta Pharma Limited announces an Equity Buyback for 2,210,500 shares, representing 1.73% for INR 3,890 million.	10.03.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Ajanta Pharma Limited

Aktien

A14QQH

INE031B01049

AJANTPHARM

Andere Sprachen

Filter